StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
3087.T$2609.00+0.00%
Fair $2609.00+0.0%

3087.T

DOUTOR NICHIRES Holdings Co., Ltd.

Consumer Cyclical / RestaurantsTokyo

$2609.00

+0.00 (+0.00%)

Fairly Valued+0.0%Fair Value $2609.00Fund rank 34/100 · Data gapFallback financials|
SA 53/C
F-Score: 8/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 26% · confianza 25%

FCF escenarios

weak_data · normalized FCF $6.4B · quality 65.7/100

Data gap 34/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 51/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

53/100

C

Piotroski

8/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific holding-company NAV/SOTP model required: targets are disabled until look-through holdings, debt and discount data exists.
Thesis & Journal · 3087.TLocal privado en este navegador · DOUTOR NICHIRES Holdings Co., Ltd.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$109.6B

P/E

15.3x

↓

EV/EBITDA

5.6x

↓

ROE

6.6%

↑

Gross Margin

60.2%

↑

Debt/Equity

0.02

↓
52-Week Range$2609
$2377$3095

TradingView lightweight chart

3087.T price, volumen y niveles de valoración

Último $2,609Periodo -31.8%
Fair value: $2,609

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+10.8%

FCF CAGR

-14.3%

FCF margin

4.3%

FCF / Net income

0.94x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $148.82B · net income $6.88B · FCF $6.44B

2022-FY → 2025-FY

Gross margin

60.2%+1.4% pts

Operating margin

6.5%+8.1% pts

Net margin

4.6%+3.5% pts

FCF margin

4.3%-5.0% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$148.82B$148.82B$140.63B$126.86B$109.36B
Net Income$6.88B$6.88B$5.49B$3.43B$1.22B
EBITDA$13.93B$13.93B$11.72B$7.95B$7.63B
EPS156.97156.97124.8977.5627.63
Gross Margin60.2%60.2%59.9%58.9%58.8%
Operating Margin6.5%6.5%5.2%2.3%-1.6%
Net Margin4.6%4.6%3.9%2.7%1.1%
Balance Sheet
Debt/Equity0.020.020.020.020.02
Current Ratio2.482.48———
Cash Flow
Free Cash Flow$6.44B$6.44B$6.87B$-221.0M$10.22B
Returns
ROE6.6%6.6%5.5%3.6%1.3%
Valuation
P/E15.2915.2916.2225.2256.24
EV/EBITDA5.565.564.757.044.68
P/B1.101.100.900.900.73
Growth & Yield
Revenue Growth5.8%5.8%10.8%16.0%—
EPS Growth25.7%25.7%61.0%180.7%—
Dividend Yield2.3%2.3%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

13.8%

razonable

EPS terminal req.

$231.51

Spread vs growth

11.9%

5Y implied EPS CAGR

12.3%

razonable

EPS terminal req.

$280.12

Spread vs growth

13.4%

10Y implied EPS CAGR

11.1%

razonable

EPS terminal req.

$451.14

Spread vs growth

14.6%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +1.4%

Total return

+1.4%

Start / end P/E

21.1x → 16.6x

EPS bridge

124.89 → 156.97

Residual

-5.4%

EPS growth+25.7%
Multiple rerating-21.1%
Dividend+2.3%
Residual / FX / buybacks / cross-term-5.4%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.